Urologix, Inc. Stock
Stocks
ULGX
US9172731047
Mining Support Services & Equipment
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | -.--% |
|
-.--% | - |
| 02/02/16 | A unknown buyer acquired substantially all of the operating assets of Urologix, Inc. | CI |
| 09/07/15 | Urologix Conducting A Strategic Review | CI |
| Market Cap | 2.13M 1.84M 1.72M 1.58M 2.97M 203M 3.01M 20.17M 7.92M 102M 7.99M 7.82M 336M | P/E 2013 |
-0.8x | P/E 2014 | -0.49x |
|---|---|---|---|---|---|
| Enterprise Value | 6.74M 5.83M 5.45M 5M 9.4M 642M 9.55M 63.91M 25.08M 322M 25.32M 24.77M 1.06B | EV / Sales 2013 |
0.4x | EV / Sales 2014 | 0.59x |
| Free-Float |
100% | Yield 2013 * |
-
| Yield 2014 | - |
| 1 month | 0 | 0 | |
| Current year | 0 | 0.02 | |
| 1 year | 0 | 0.03 | |
| 3 years | 0 | 0.04 | |
| 5 years | 0 | 0.04 | |
| 10 years | 0 | 0.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Madson
DFI | Director of Finance/CFO | 65 | 01/04/2015 |
Lisa Ackermann
SAM | Sales & Marketing | 53 | 16/06/2011 |
| Director | Title | Age | Since |
|---|---|---|---|
Mitchell Dann
CHM | Chairman | 65 | 29/05/1991 |
Sidney Emery
BRD | Director/Board Member | 76 | 03/10/2005 |
| Director/Board Member | 59 | 06/08/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | -.--% | -.--% | 2.13K | ||
| +1.15% | +0.50% | -25.35% | +11.96% | 3.15B | ||
| 0.00% | +8.81% | +36.67% | +1,319.67% | 2.89B | ||
| +9.99% | +56.53% | +14.43% | +387.49% | 2.22B | ||
| +0.10% | -0.42% | -32.48% | -17.12% | 1.75B | ||
| +1.51% | +4.12% | +184.51% | +531.25% | 1.5B | ||
| +0.31% | +8.22% | +17.70% | +21.24% | 529M | ||
| -0.93% | +9.18% | +16.56% | +27.38% | 326M | ||
| +2.92% | +22.08% | +54.10% | +56.67% | 198M | ||
| +5.26% | +6.06% | +37.25% | +125.81% | 121M | ||
| Average | +2.03% | +10.17% | +30.34% | +246.43% | 1.27B | |
| Weighted average by Cap. | +2.31% | +11.18% | +24.27% | +435.28% |
| 2013 | 2014 | |
|---|---|---|
| Net sales | 16.48M 14.26M 13.32M 12.21M 22.97M 1.57B 23.34M 156M 61.32M 786M 61.9M 60.55M 2.6B | 14.01M 12.12M 11.32M 10.38M 19.53M 1.33B 19.84M 133M 52.12M 668M 52.62M 51.47M 2.21B |
| Net income | -4.29M -3.71M -3.47M -3.18M -5.98M -408M -6.08M -40.68M -15.97M -205M -16.12M -15.76M -677M | -7.61M -6.58M -6.15M -5.64M -10.6M -724M -10.77M -72.1M -28.3M -363M -28.57M -27.94M -1.2B |
| Net Debt | 3.04M 2.63M 2.46M 2.25M 4.24M 290M 4.31M 28.84M 11.32M 145M 11.43M 11.18M 480M | 4.62M 3.99M 3.73M 3.42M 6.43M 439M 6.53M 43.74M 17.17M 220M 17.33M 16.95M 728M |
Employees
61
- Stock Market
- Stocks
- ULGX Stock
Select your edition
All financial news and data tailored to specific country editions
















